{"organizations": [], "uuid": "0d63d90217f9964c026a49fd064ed2477eb71187", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180302.html", "section_title": "Archive News &amp; Video for Friday, 02 Mar 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-vaxart-says-data-shows-orally-admi/brief-vaxart-says-data-shows-orally-administered-norovirus-tablet-vaccine-was-well-tolerated-idUSFWN1QK0QK", "country": "US", "domain_rank": 408, "title": "BRIEF-Vaxart Says Data Shows Orally Administered Norovirus Tablet Vaccine Was Well-Tolerated", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.999, "site_type": "news", "published": "2018-03-02T21:24:00.000+02:00", "replies_count": 0, "uuid": "0d63d90217f9964c026a49fd064ed2477eb71187"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-vaxart-says-data-shows-orally-admi/brief-vaxart-says-data-shows-orally-administered-norovirus-tablet-vaccine-was-well-tolerated-idUSFWN1QK0QK", "ord_in_thread": 0, "title": "BRIEF-Vaxart Says Data Shows Orally Administered Norovirus Tablet Vaccine Was Well-Tolerated", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "vaxart inc", "sentiment": "negative"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "March 2 (Reuters) - Vaxart Inc:\n* VAXART - DATA SHOWS ORALLY ADMINISTERED NOROVIRUS TABLET VACCINE WAS WELL-TOLERATED, GENERATED ROBUST SYSTEMIC AND LOCAL INTESTINAL IMMUNE RESPONSES\n* VAXART INC - DID NOT SEE ANY EVIDENCE OF ANTI-VECTOR IMMUNITY WITH NOROVIRUS ORAL TABLET VACCINE Source text for Eikon: Further company coverage:\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-03-02T21:24:00.000+02:00", "crawled": "2018-03-03T17:41:03.029+02:00", "highlightTitle": ""}